nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Acetylsalicylic acid—TP53—kidney cancer	0.00981	0.298	CrCbGaD
Nitazoxanide—Meloxicam—PTGS1—kidney cancer	0.00584	0.177	CrCbGaD
Nitazoxanide—Salsalate—PTGS1—kidney cancer	0.00449	0.136	CrCbGaD
Nitazoxanide—Acetylsalicylic acid—PTGS1—kidney cancer	0.00336	0.102	CrCbGaD
Nitazoxanide—Meloxicam—PTGS2—kidney cancer	0.00334	0.101	CrCbGaD
Nitazoxanide—Salsalate—PTGS2—kidney cancer	0.00257	0.0779	CrCbGaD
Nitazoxanide—Acetylsalicylic acid—PTGS2—kidney cancer	0.00192	0.0582	CrCbGaD
Nitazoxanide—Decreased appetite—Sorafenib—kidney cancer	0.00167	0.00173	CcSEcCtD
Nitazoxanide—Anorexia—Dactinomycin—kidney cancer	0.00167	0.00173	CcSEcCtD
Nitazoxanide—Nausea—Pazopanib—kidney cancer	0.00167	0.00173	CcSEcCtD
Nitazoxanide—Hypertension—Vincristine—kidney cancer	0.00166	0.00172	CcSEcCtD
Nitazoxanide—Pain—Sorafenib—kidney cancer	0.00165	0.0017	CcSEcCtD
Nitazoxanide—Constipation—Sorafenib—kidney cancer	0.00165	0.0017	CcSEcCtD
Nitazoxanide—Malaise—Gemcitabine—kidney cancer	0.00164	0.0017	CcSEcCtD
Nitazoxanide—Hypersensitivity—Vinblastine—kidney cancer	0.00164	0.0017	CcSEcCtD
Nitazoxanide—Myalgia—Vincristine—kidney cancer	0.00164	0.00169	CcSEcCtD
Nitazoxanide—Hypersensitivity—Everolimus—kidney cancer	0.00164	0.00169	CcSEcCtD
Nitazoxanide—Dyspepsia—Sunitinib—kidney cancer	0.00163	0.00169	CcSEcCtD
Nitazoxanide—Acetylsalicylic acid—ABCB1—kidney cancer	0.00163	0.0495	CrCbGaD
Nitazoxanide—Decreased appetite—Sunitinib—kidney cancer	0.00161	0.00167	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.0016	0.00165	CcSEcCtD
Nitazoxanide—Asthenia—Vinblastine—kidney cancer	0.0016	0.00165	CcSEcCtD
Nitazoxanide—Asthenia—Everolimus—kidney cancer	0.00159	0.00165	CcSEcCtD
Nitazoxanide—Pain—Sunitinib—kidney cancer	0.00159	0.00164	CcSEcCtD
Nitazoxanide—Constipation—Sunitinib—kidney cancer	0.00159	0.00164	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Sorafenib—kidney cancer	0.00158	0.00163	CcSEcCtD
Nitazoxanide—Hypertension—Gemcitabine—kidney cancer	0.00157	0.00163	CcSEcCtD
Nitazoxanide—Chills—Paclitaxel—kidney cancer	0.00157	0.00163	CcSEcCtD
Nitazoxanide—Pruritus—Everolimus—kidney cancer	0.00157	0.00162	CcSEcCtD
Nitazoxanide—Oedema—Vincristine—kidney cancer	0.00157	0.00162	CcSEcCtD
Nitazoxanide—Infection—Vincristine—kidney cancer	0.00156	0.00161	CcSEcCtD
Nitazoxanide—Myalgia—Gemcitabine—kidney cancer	0.00155	0.0016	CcSEcCtD
Nitazoxanide—Asthenia—Erlotinib—kidney cancer	0.00154	0.00159	CcSEcCtD
Nitazoxanide—Discomfort—Gemcitabine—kidney cancer	0.00153	0.00159	CcSEcCtD
Nitazoxanide—Decreased appetite—Dactinomycin—kidney cancer	0.00153	0.00158	CcSEcCtD
Nitazoxanide—Diarrhoea—Vinblastine—kidney cancer	0.00152	0.00158	CcSEcCtD
Nitazoxanide—Abdominal pain—Sorafenib—kidney cancer	0.00152	0.00157	CcSEcCtD
Nitazoxanide—Body temperature increased—Sorafenib—kidney cancer	0.00152	0.00157	CcSEcCtD
Nitazoxanide—Diarrhoea—Everolimus—kidney cancer	0.00152	0.00157	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Sunitinib—kidney cancer	0.00152	0.00157	CcSEcCtD
Nitazoxanide—Pruritus—Erlotinib—kidney cancer	0.00151	0.00157	CcSEcCtD
Nitazoxanide—Epistaxis—Capecitabine—kidney cancer	0.00151	0.00156	CcSEcCtD
Nitazoxanide—Flatulence—Paclitaxel—kidney cancer	0.0015	0.00155	CcSEcCtD
Nitazoxanide—Pain—Dactinomycin—kidney cancer	0.0015	0.00155	CcSEcCtD
Nitazoxanide—Anorexia—Vincristine—kidney cancer	0.00149	0.00155	CcSEcCtD
Nitazoxanide—Oedema—Gemcitabine—kidney cancer	0.00149	0.00154	CcSEcCtD
Nitazoxanide—Infection—Gemcitabine—kidney cancer	0.00148	0.00153	CcSEcCtD
Nitazoxanide—Back pain—Paclitaxel—kidney cancer	0.00148	0.00153	CcSEcCtD
Nitazoxanide—Dizziness—Vinblastine—kidney cancer	0.00147	0.00152	CcSEcCtD
Nitazoxanide—Dizziness—Everolimus—kidney cancer	0.00147	0.00152	CcSEcCtD
Nitazoxanide—Muscle spasms—Paclitaxel—kidney cancer	0.00147	0.00152	CcSEcCtD
Nitazoxanide—Abdominal pain—Sunitinib—kidney cancer	0.00147	0.00152	CcSEcCtD
Nitazoxanide—Body temperature increased—Sunitinib—kidney cancer	0.00147	0.00152	CcSEcCtD
Nitazoxanide—Diarrhoea—Erlotinib—kidney cancer	0.00147	0.00152	CcSEcCtD
Nitazoxanide—Feeling abnormal—Dactinomycin—kidney cancer	0.00145	0.0015	CcSEcCtD
Nitazoxanide—Rhinitis—Capecitabine—kidney cancer	0.00144	0.00149	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00143	0.00148	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Capecitabine—kidney cancer	0.00143	0.00148	CcSEcCtD
Nitazoxanide—Tremor—Paclitaxel—kidney cancer	0.00143	0.00148	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00143	0.00148	CcSEcCtD
Nitazoxanide—Pharyngitis—Capecitabine—kidney cancer	0.00143	0.00148	CcSEcCtD
Nitazoxanide—Increased appetite—Doxorubicin—kidney cancer	0.00143	0.00148	CcSEcCtD
Nitazoxanide—Hypersensitivity—Sorafenib—kidney cancer	0.00142	0.00147	CcSEcCtD
Nitazoxanide—Insomnia—Vincristine—kidney cancer	0.00142	0.00147	CcSEcCtD
Nitazoxanide—Anorexia—Gemcitabine—kidney cancer	0.00142	0.00147	CcSEcCtD
Nitazoxanide—Vomiting—Vinblastine—kidney cancer	0.00142	0.00146	CcSEcCtD
Nitazoxanide—Dizziness—Erlotinib—kidney cancer	0.00142	0.00146	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Paclitaxel—kidney cancer	0.00142	0.00146	CcSEcCtD
Nitazoxanide—Vomiting—Everolimus—kidney cancer	0.00141	0.00146	CcSEcCtD
Nitazoxanide—Anaemia—Paclitaxel—kidney cancer	0.00141	0.00146	CcSEcCtD
Nitazoxanide—Rash—Everolimus—kidney cancer	0.0014	0.00145	CcSEcCtD
Nitazoxanide—Dermatitis—Everolimus—kidney cancer	0.0014	0.00145	CcSEcCtD
Nitazoxanide—Headache—Vinblastine—kidney cancer	0.0014	0.00144	CcSEcCtD
Nitazoxanide—Headache—Everolimus—kidney cancer	0.00139	0.00144	CcSEcCtD
Nitazoxanide—Abdominal pain—Dactinomycin—kidney cancer	0.00139	0.00143	CcSEcCtD
Nitazoxanide—Body temperature increased—Dactinomycin—kidney cancer	0.00139	0.00143	CcSEcCtD
Nitazoxanide—Asthenia—Sorafenib—kidney cancer	0.00138	0.00143	CcSEcCtD
Nitazoxanide—Malaise—Paclitaxel—kidney cancer	0.00138	0.00142	CcSEcCtD
Nitazoxanide—Syncope—Paclitaxel—kidney cancer	0.00137	0.00141	CcSEcCtD
Nitazoxanide—Hypersensitivity—Sunitinib—kidney cancer	0.00137	0.00141	CcSEcCtD
Nitazoxanide—Decreased appetite—Vincristine—kidney cancer	0.00136	0.00141	CcSEcCtD
Nitazoxanide—Pruritus—Sorafenib—kidney cancer	0.00136	0.00141	CcSEcCtD
Nitazoxanide—Vomiting—Erlotinib—kidney cancer	0.00136	0.00141	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00136	0.0014	CcSEcCtD
Nitazoxanide—Rash—Erlotinib—kidney cancer	0.00135	0.0014	CcSEcCtD
Nitazoxanide—Dermatitis—Erlotinib—kidney cancer	0.00135	0.00139	CcSEcCtD
Nitazoxanide—Insomnia—Gemcitabine—kidney cancer	0.00135	0.00139	CcSEcCtD
Nitazoxanide—Headache—Erlotinib—kidney cancer	0.00134	0.00139	CcSEcCtD
Nitazoxanide—Loss of consciousness—Paclitaxel—kidney cancer	0.00134	0.00139	CcSEcCtD
Nitazoxanide—Pain—Vincristine—kidney cancer	0.00134	0.00139	CcSEcCtD
Nitazoxanide—Constipation—Vincristine—kidney cancer	0.00134	0.00139	CcSEcCtD
Nitazoxanide—Asthenia—Sunitinib—kidney cancer	0.00133	0.00138	CcSEcCtD
Nitazoxanide—Nausea—Vinblastine—kidney cancer	0.00132	0.00137	CcSEcCtD
Nitazoxanide—Somnolence—Gemcitabine—kidney cancer	0.00132	0.00137	CcSEcCtD
Nitazoxanide—Nausea—Everolimus—kidney cancer	0.00132	0.00136	CcSEcCtD
Nitazoxanide—Diarrhoea—Sorafenib—kidney cancer	0.00132	0.00136	CcSEcCtD
Nitazoxanide—Hypertension—Paclitaxel—kidney cancer	0.00132	0.00136	CcSEcCtD
Nitazoxanide—Pruritus—Sunitinib—kidney cancer	0.00131	0.00136	CcSEcCtD
Nitazoxanide—Myalgia—Paclitaxel—kidney cancer	0.0013	0.00134	CcSEcCtD
Nitazoxanide—Decreased appetite—Gemcitabine—kidney cancer	0.00129	0.00134	CcSEcCtD
Nitazoxanide—Hypersensitivity—Dactinomycin—kidney cancer	0.00129	0.00134	CcSEcCtD
Nitazoxanide—Chills—Capecitabine—kidney cancer	0.00129	0.00133	CcSEcCtD
Nitazoxanide—Discomfort—Paclitaxel—kidney cancer	0.00128	0.00133	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Vincristine—kidney cancer	0.00128	0.00133	CcSEcCtD
Nitazoxanide—Dizziness—Sorafenib—kidney cancer	0.00127	0.00132	CcSEcCtD
Nitazoxanide—Pain—Gemcitabine—kidney cancer	0.00127	0.00132	CcSEcCtD
Nitazoxanide—Constipation—Gemcitabine—kidney cancer	0.00127	0.00132	CcSEcCtD
Nitazoxanide—Nausea—Erlotinib—kidney cancer	0.00127	0.00132	CcSEcCtD
Nitazoxanide—Dry mouth—Paclitaxel—kidney cancer	0.00127	0.00131	CcSEcCtD
Nitazoxanide—Diarrhoea—Sunitinib—kidney cancer	0.00127	0.00131	CcSEcCtD
Nitazoxanide—Asthenia—Dactinomycin—kidney cancer	0.00126	0.0013	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Doxorubicin—kidney cancer	0.00126	0.0013	CcSEcCtD
Nitazoxanide—Oedema—Paclitaxel—kidney cancer	0.00125	0.00129	CcSEcCtD
Nitazoxanide—Abdominal pain—Vincristine—kidney cancer	0.00124	0.00128	CcSEcCtD
Nitazoxanide—Body temperature increased—Vincristine—kidney cancer	0.00124	0.00128	CcSEcCtD
Nitazoxanide—Infection—Paclitaxel—kidney cancer	0.00124	0.00128	CcSEcCtD
Nitazoxanide—Flatulence—Capecitabine—kidney cancer	0.00123	0.00128	CcSEcCtD
Nitazoxanide—Dizziness—Sunitinib—kidney cancer	0.00123	0.00127	CcSEcCtD
Nitazoxanide—Feeling abnormal—Gemcitabine—kidney cancer	0.00123	0.00127	CcSEcCtD
Nitazoxanide—Shock—Paclitaxel—kidney cancer	0.00123	0.00127	CcSEcCtD
Nitazoxanide—Vomiting—Sorafenib—kidney cancer	0.00122	0.00127	CcSEcCtD
Nitazoxanide—Tachycardia—Paclitaxel—kidney cancer	0.00122	0.00126	CcSEcCtD
Nitazoxanide—Rash—Sorafenib—kidney cancer	0.00121	0.00126	CcSEcCtD
Nitazoxanide—Dermatitis—Sorafenib—kidney cancer	0.00121	0.00125	CcSEcCtD
Nitazoxanide—Back pain—Capecitabine—kidney cancer	0.00121	0.00125	CcSEcCtD
Nitazoxanide—Headache—Sorafenib—kidney cancer	0.00121	0.00125	CcSEcCtD
Nitazoxanide—Muscle spasms—Capecitabine—kidney cancer	0.0012	0.00124	CcSEcCtD
Nitazoxanide—Diarrhoea—Dactinomycin—kidney cancer	0.0012	0.00124	CcSEcCtD
Nitazoxanide—Anorexia—Paclitaxel—kidney cancer	0.00119	0.00123	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.00118	0.00122	CcSEcCtD
Nitazoxanide—Vomiting—Sunitinib—kidney cancer	0.00118	0.00122	CcSEcCtD
Nitazoxanide—Body temperature increased—Gemcitabine—kidney cancer	0.00118	0.00122	CcSEcCtD
Nitazoxanide—Tremor—Capecitabine—kidney cancer	0.00117	0.00121	CcSEcCtD
Nitazoxanide—Rash—Sunitinib—kidney cancer	0.00117	0.00121	CcSEcCtD
Nitazoxanide—Dermatitis—Sunitinib—kidney cancer	0.00117	0.00121	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Capecitabine—kidney cancer	0.00116	0.0012	CcSEcCtD
Nitazoxanide—Headache—Sunitinib—kidney cancer	0.00116	0.0012	CcSEcCtD
Nitazoxanide—Influenza—Doxorubicin—kidney cancer	0.00116	0.0012	CcSEcCtD
Nitazoxanide—Anaemia—Capecitabine—kidney cancer	0.00116	0.0012	CcSEcCtD
Nitazoxanide—Hypersensitivity—Vincristine—kidney cancer	0.00116	0.00119	CcSEcCtD
Nitazoxanide—Nausea—Sorafenib—kidney cancer	0.00114	0.00118	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00113	0.00117	CcSEcCtD
Nitazoxanide—Malaise—Capecitabine—kidney cancer	0.00113	0.00117	CcSEcCtD
Nitazoxanide—Insomnia—Paclitaxel—kidney cancer	0.00113	0.00116	CcSEcCtD
Nitazoxanide—Asthenia—Vincristine—kidney cancer	0.00112	0.00116	CcSEcCtD
Nitazoxanide—Syncope—Capecitabine—kidney cancer	0.00112	0.00116	CcSEcCtD
Nitazoxanide—Vomiting—Dactinomycin—kidney cancer	0.00112	0.00115	CcSEcCtD
Nitazoxanide—Somnolence—Paclitaxel—kidney cancer	0.00111	0.00114	CcSEcCtD
Nitazoxanide—Rash—Dactinomycin—kidney cancer	0.00111	0.00114	CcSEcCtD
Nitazoxanide—Nausea—Sunitinib—kidney cancer	0.0011	0.00114	CcSEcCtD
Nitazoxanide—Loss of consciousness—Capecitabine—kidney cancer	0.0011	0.00114	CcSEcCtD
Nitazoxanide—Dyspepsia—Paclitaxel—kidney cancer	0.0011	0.00113	CcSEcCtD
Nitazoxanide—Dysuria—Doxorubicin—kidney cancer	0.00108	0.00112	CcSEcCtD
Nitazoxanide—Decreased appetite—Paclitaxel—kidney cancer	0.00108	0.00112	CcSEcCtD
Nitazoxanide—Hypertension—Capecitabine—kidney cancer	0.00108	0.00112	CcSEcCtD
Nitazoxanide—Diarrhoea—Vincristine—kidney cancer	0.00107	0.00111	CcSEcCtD
Nitazoxanide—Asthenia—Gemcitabine—kidney cancer	0.00107	0.0011	CcSEcCtD
Nitazoxanide—Myalgia—Capecitabine—kidney cancer	0.00107	0.0011	CcSEcCtD
Nitazoxanide—Pain—Paclitaxel—kidney cancer	0.00106	0.0011	CcSEcCtD
Nitazoxanide—Constipation—Paclitaxel—kidney cancer	0.00106	0.0011	CcSEcCtD
Nitazoxanide—Discomfort—Capecitabine—kidney cancer	0.00105	0.00109	CcSEcCtD
Nitazoxanide—Pruritus—Gemcitabine—kidney cancer	0.00105	0.00109	CcSEcCtD
Nitazoxanide—Dry mouth—Capecitabine—kidney cancer	0.00104	0.00108	CcSEcCtD
Nitazoxanide—Nausea—Dactinomycin—kidney cancer	0.00104	0.00108	CcSEcCtD
Nitazoxanide—Dizziness—Vincristine—kidney cancer	0.00104	0.00107	CcSEcCtD
Nitazoxanide—Feeling abnormal—Paclitaxel—kidney cancer	0.00103	0.00106	CcSEcCtD
Nitazoxanide—Oedema—Capecitabine—kidney cancer	0.00102	0.00106	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00102	0.00105	CcSEcCtD
Nitazoxanide—Diarrhoea—Gemcitabine—kidney cancer	0.00102	0.00105	CcSEcCtD
Nitazoxanide—Infection—Capecitabine—kidney cancer	0.00102	0.00105	CcSEcCtD
Nitazoxanide—Shock—Capecitabine—kidney cancer	0.00101	0.00104	CcSEcCtD
Nitazoxanide—Tachycardia—Capecitabine—kidney cancer	0.000997	0.00103	CcSEcCtD
Nitazoxanide—Vomiting—Vincristine—kidney cancer	0.000997	0.00103	CcSEcCtD
Nitazoxanide—Rash—Vincristine—kidney cancer	0.000989	0.00102	CcSEcCtD
Nitazoxanide—Dermatitis—Vincristine—kidney cancer	0.000988	0.00102	CcSEcCtD
Nitazoxanide—Body temperature increased—Paclitaxel—kidney cancer	0.000984	0.00102	CcSEcCtD
Nitazoxanide—Abdominal pain—Paclitaxel—kidney cancer	0.000984	0.00102	CcSEcCtD
Nitazoxanide—Headache—Vincristine—kidney cancer	0.000982	0.00102	CcSEcCtD
Nitazoxanide—Epistaxis—Doxorubicin—kidney cancer	0.000974	0.00101	CcSEcCtD
Nitazoxanide—Anorexia—Capecitabine—kidney cancer	0.000974	0.00101	CcSEcCtD
Nitazoxanide—Vomiting—Gemcitabine—kidney cancer	0.000946	0.000978	CcSEcCtD
Nitazoxanide—Rash—Gemcitabine—kidney cancer	0.000938	0.00097	CcSEcCtD
Nitazoxanide—Dermatitis—Gemcitabine—kidney cancer	0.000937	0.000969	CcSEcCtD
Nitazoxanide—Headache—Gemcitabine—kidney cancer	0.000932	0.000964	CcSEcCtD
Nitazoxanide—Nausea—Vincristine—kidney cancer	0.000931	0.000963	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000931	0.000963	CcSEcCtD
Nitazoxanide—Rhinitis—Doxorubicin—kidney cancer	0.00093	0.000961	CcSEcCtD
Nitazoxanide—Insomnia—Capecitabine—kidney cancer	0.000924	0.000956	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Doxorubicin—kidney cancer	0.000923	0.000954	CcSEcCtD
Nitazoxanide—Pharyngitis—Doxorubicin—kidney cancer	0.00092	0.000952	CcSEcCtD
Nitazoxanide—Hypersensitivity—Paclitaxel—kidney cancer	0.000917	0.000949	CcSEcCtD
Nitazoxanide—Dyspepsia—Capecitabine—kidney cancer	0.0009	0.00093	CcSEcCtD
Nitazoxanide—Asthenia—Paclitaxel—kidney cancer	0.000893	0.000924	CcSEcCtD
Nitazoxanide—Decreased appetite—Capecitabine—kidney cancer	0.000888	0.000919	CcSEcCtD
Nitazoxanide—Nausea—Gemcitabine—kidney cancer	0.000883	0.000914	CcSEcCtD
Nitazoxanide—Pruritus—Paclitaxel—kidney cancer	0.000881	0.000911	CcSEcCtD
Nitazoxanide—Pain—Capecitabine—kidney cancer	0.000874	0.000904	CcSEcCtD
Nitazoxanide—Constipation—Capecitabine—kidney cancer	0.000874	0.000904	CcSEcCtD
Nitazoxanide—Diarrhoea—Paclitaxel—kidney cancer	0.000852	0.000881	CcSEcCtD
Nitazoxanide—Feeling abnormal—Capecitabine—kidney cancer	0.000842	0.000871	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Capecitabine—kidney cancer	0.000836	0.000864	CcSEcCtD
Nitazoxanide—Chills—Doxorubicin—kidney cancer	0.000832	0.00086	CcSEcCtD
Nitazoxanide—Dizziness—Paclitaxel—kidney cancer	0.000823	0.000852	CcSEcCtD
Nitazoxanide—Body temperature increased—Capecitabine—kidney cancer	0.000808	0.000835	CcSEcCtD
Nitazoxanide—Abdominal pain—Capecitabine—kidney cancer	0.000808	0.000835	CcSEcCtD
Nitazoxanide—Flatulence—Doxorubicin—kidney cancer	0.000795	0.000822	CcSEcCtD
Nitazoxanide—Vomiting—Paclitaxel—kidney cancer	0.000792	0.000819	CcSEcCtD
Nitazoxanide—Rash—Paclitaxel—kidney cancer	0.000785	0.000812	CcSEcCtD
Nitazoxanide—Dermatitis—Paclitaxel—kidney cancer	0.000784	0.000811	CcSEcCtD
Nitazoxanide—Back pain—Doxorubicin—kidney cancer	0.000781	0.000807	CcSEcCtD
Nitazoxanide—Headache—Paclitaxel—kidney cancer	0.00078	0.000807	CcSEcCtD
Nitazoxanide—Muscle spasms—Doxorubicin—kidney cancer	0.000776	0.000802	CcSEcCtD
Nitazoxanide—Hypersensitivity—Capecitabine—kidney cancer	0.000753	0.000779	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Doxorubicin—kidney cancer	0.000749	0.000774	CcSEcCtD
Nitazoxanide—Anaemia—Doxorubicin—kidney cancer	0.000746	0.000771	CcSEcCtD
Nitazoxanide—Nausea—Paclitaxel—kidney cancer	0.00074	0.000765	CcSEcCtD
Nitazoxanide—Asthenia—Capecitabine—kidney cancer	0.000733	0.000758	CcSEcCtD
Nitazoxanide—Malaise—Doxorubicin—kidney cancer	0.000728	0.000753	CcSEcCtD
Nitazoxanide—Syncope—Doxorubicin—kidney cancer	0.000724	0.000748	CcSEcCtD
Nitazoxanide—Pruritus—Capecitabine—kidney cancer	0.000723	0.000748	CcSEcCtD
Nitazoxanide—Loss of consciousness—Doxorubicin—kidney cancer	0.000709	0.000734	CcSEcCtD
Nitazoxanide—Diarrhoea—Capecitabine—kidney cancer	0.000699	0.000723	CcSEcCtD
Nitazoxanide—Hypertension—Doxorubicin—kidney cancer	0.000697	0.000721	CcSEcCtD
Nitazoxanide—Myalgia—Doxorubicin—kidney cancer	0.000687	0.000711	CcSEcCtD
Nitazoxanide—Discomfort—Doxorubicin—kidney cancer	0.000679	0.000702	CcSEcCtD
Nitazoxanide—Dizziness—Capecitabine—kidney cancer	0.000676	0.000699	CcSEcCtD
Nitazoxanide—Dry mouth—Doxorubicin—kidney cancer	0.000672	0.000695	CcSEcCtD
Nitazoxanide—Oedema—Doxorubicin—kidney cancer	0.000659	0.000681	CcSEcCtD
Nitazoxanide—Infection—Doxorubicin—kidney cancer	0.000654	0.000677	CcSEcCtD
Nitazoxanide—Vomiting—Capecitabine—kidney cancer	0.00065	0.000672	CcSEcCtD
Nitazoxanide—Shock—Doxorubicin—kidney cancer	0.000648	0.00067	CcSEcCtD
Nitazoxanide—Rash—Capecitabine—kidney cancer	0.000644	0.000666	CcSEcCtD
Nitazoxanide—Dermatitis—Capecitabine—kidney cancer	0.000644	0.000666	CcSEcCtD
Nitazoxanide—Tachycardia—Doxorubicin—kidney cancer	0.000643	0.000665	CcSEcCtD
Nitazoxanide—Headache—Capecitabine—kidney cancer	0.00064	0.000662	CcSEcCtD
Nitazoxanide—Anorexia—Doxorubicin—kidney cancer	0.000628	0.000649	CcSEcCtD
Nitazoxanide—Nausea—Capecitabine—kidney cancer	0.000607	0.000628	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.0006	0.000621	CcSEcCtD
Nitazoxanide—Insomnia—Doxorubicin—kidney cancer	0.000596	0.000616	CcSEcCtD
Nitazoxanide—Somnolence—Doxorubicin—kidney cancer	0.000586	0.000606	CcSEcCtD
Nitazoxanide—Dyspepsia—Doxorubicin—kidney cancer	0.00058	0.0006	CcSEcCtD
Nitazoxanide—Decreased appetite—Doxorubicin—kidney cancer	0.000573	0.000592	CcSEcCtD
Nitazoxanide—Constipation—Doxorubicin—kidney cancer	0.000563	0.000583	CcSEcCtD
Nitazoxanide—Pain—Doxorubicin—kidney cancer	0.000563	0.000583	CcSEcCtD
Nitazoxanide—Feeling abnormal—Doxorubicin—kidney cancer	0.000543	0.000561	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000539	0.000557	CcSEcCtD
Nitazoxanide—Body temperature increased—Doxorubicin—kidney cancer	0.000521	0.000538	CcSEcCtD
Nitazoxanide—Abdominal pain—Doxorubicin—kidney cancer	0.000521	0.000538	CcSEcCtD
Nitazoxanide—Hypersensitivity—Doxorubicin—kidney cancer	0.000485	0.000502	CcSEcCtD
Nitazoxanide—Asthenia—Doxorubicin—kidney cancer	0.000473	0.000489	CcSEcCtD
Nitazoxanide—Pruritus—Doxorubicin—kidney cancer	0.000466	0.000482	CcSEcCtD
Nitazoxanide—Diarrhoea—Doxorubicin—kidney cancer	0.000451	0.000466	CcSEcCtD
Nitazoxanide—Dizziness—Doxorubicin—kidney cancer	0.000436	0.00045	CcSEcCtD
Nitazoxanide—Vomiting—Doxorubicin—kidney cancer	0.000419	0.000433	CcSEcCtD
Nitazoxanide—Rash—Doxorubicin—kidney cancer	0.000415	0.000429	CcSEcCtD
Nitazoxanide—Dermatitis—Doxorubicin—kidney cancer	0.000415	0.000429	CcSEcCtD
Nitazoxanide—Headache—Doxorubicin—kidney cancer	0.000413	0.000427	CcSEcCtD
Nitazoxanide—Nausea—Doxorubicin—kidney cancer	0.000391	0.000405	CcSEcCtD
